Prostatic Neoplasms, Castration-Resistant
"Prostatic Neoplasms, Castration-Resistant" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.
| Descriptor ID |
D064129
|
| MeSH Number(s) |
C04.588.945.440.770.500 C12.294.260.750.500 C12.294.565.625.500 C12.758.409.750.500
|
| Concept/Terms |
Prostatic Neoplasms, Castration-Resistant- Prostatic Neoplasms, Castration-Resistant
- Castration-Resistant Prostatic Neoplasm
- Neoplasm, Castration-Resistant Prostatic
- Neoplasms, Castration-Resistant Prostatic
- Prostatic Neoplasm, Castration-Resistant
- Prostatic Neoplasms, Castration Resistant
- Androgen-Insensitive Prostatic Neoplasms
- Androgen Insensitive Prostatic Neoplasms
- Androgen-Resistant Prostatic Neoplasms
- Androgen Resistant Prostatic Neoplasms
- Prostatic Neoplasms, Hormone Refractory
- Hormone Refractory Prostatic Neoplasms
- Prostatic Neoplasms, Androgen-Independent
- Androgen-Independent Prostatic Neoplasm
- Neoplasm, Androgen-Independent Prostatic
- Neoplasms, Androgen-Independent Prostatic
- Prostatic Neoplasm, Androgen-Independent
- Prostatic Neoplasms, Androgen Independent
- Prostatic Neoplasms, Androgen-Insensitive
- Androgen-Insensitive Prostatic Neoplasm
- Neoplasm, Androgen-Insensitive Prostatic
- Neoplasms, Androgen-Insensitive Prostatic
- Prostatic Neoplasm, Androgen-Insensitive
- Prostatic Neoplasms, Androgen Insensitive
- Prostatic Neoplasms, Androgen-Resistant
- Androgen-Resistant Prostatic Neoplasm
- Neoplasm, Androgen-Resistant Prostatic
- Neoplasms, Androgen-Resistant Prostatic
- Prostatic Neoplasm, Androgen-Resistant
- Prostatic Neoplasms, Androgen Resistant
- Androgen-Independent Prostatic Neoplasms
- Androgen Independent Prostatic Neoplasms
- Castration-Resistant Prostatic Neoplasms
- Castration Resistant Prostatic Neoplasms
Prostatic Cancer, Castration-Resistant- Prostatic Cancer, Castration-Resistant
- Cancer, Castration-Resistant Prostatic
- Cancers, Castration-Resistant Prostatic
- Castration-Resistant Prostatic Cancers
- Prostatic Cancer, Castration Resistant
- Prostatic Cancers, Castration-Resistant
- Androgen-Insensitive Prostatic Cancer
- Androgen Insensitive Prostatic Cancer
- Androgen-Resistant Prostatic Cancer
- Androgen Resistant Prostatic Cancer
- Prostatic Cancer, Hormone Refractory
- Hormone Refractory Prostatic Cancer
- Prostatic Cancer, Androgen-Independent
- Androgen-Independent Prostatic Cancers
- Cancer, Androgen-Independent Prostatic
- Cancers, Androgen-Independent Prostatic
- Prostatic Cancer, Androgen Independent
- Prostatic Cancers, Androgen-Independent
- Prostatic Cancer, Androgen-Insensitive
- Androgen-Insensitive Prostatic Cancers
- Cancer, Androgen-Insensitive Prostatic
- Cancers, Androgen-Insensitive Prostatic
- Prostatic Cancer, Androgen Insensitive
- Prostatic Cancers, Androgen-Insensitive
- Prostatic Cancer, Androgen-Resistant
- Androgen-Resistant Prostatic Cancers
- Cancer, Androgen-Resistant Prostatic
- Cancers, Androgen-Resistant Prostatic
- Prostatic Cancer, Androgen Resistant
- Prostatic Cancers, Androgen-Resistant
- Androgen-Independent Prostatic Cancer
- Androgen Independent Prostatic Cancer
- Castration-Resistant Prostatic Cancer
- Castration Resistant Prostatic Cancer
|
Below are MeSH descriptors whose meaning is more general than "Prostatic Neoplasms, Castration-Resistant".
Below are MeSH descriptors whose meaning is more specific than "Prostatic Neoplasms, Castration-Resistant".
This graph shows the total number of publications written about "Prostatic Neoplasms, Castration-Resistant" by people in this website by year, and whether "Prostatic Neoplasms, Castration-Resistant" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 2 | 0 | 2 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 1 | 3 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 3 | 0 | 3 |
| 2019 | 1 | 1 | 2 |
| 2020 | 3 | 0 | 3 |
| 2021 | 4 | 0 | 4 |
| 2022 | 2 | 0 | 2 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prostatic Neoplasms, Castration-Resistant" by people in Profiles.
-
Generating a Murine PTEN Null Cell Line to Discover the Key Role of p110?-PAK1 in Castration-Resistant Prostate Cancer Invasion. Mol Cancer Res. 2023 12 01; 21(12):1317-1328.
-
Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer. Prostate. 2022 09; 82(13):1264-1272.
-
Recent advances in the treatment of advanced prostate cancer: maximizing existing therapies while searching for novel solutions. Curr Opin Oncol. 2022 05 01; 34(3):228-233.
-
A phase II study of docetaxel plus lycopene in metastatic castrate resistant prostate cancer. Biomed Pharmacother. 2021 Nov; 143:112226.
-
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer. Cancer. 2021 08 15; 127(16):2954-2965.
-
Highlighting recent treatment advances in metastatic prostate cancer: expanding the treatment arsenal. Curr Opin Oncol. 2021 05 01; 33(3):252-256.
-
Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update. J Clin Oncol. 2021 04 10; 39(11):1274-1305.
-
Evolving understanding and categorization of prostate cancer: preventing progression to metastatic castration-resistant prostate cancer: RADAR IV. Can J Urol. 2020 10; 27(5):10352-10362.
-
Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer. Cancer Treat Res Commun. 2020; 24:100193.
-
Recent progress in treating advanced prostate cancer. Curr Opin Oncol. 2020 05; 32(3):210-215.